Evidence map›Paper›PMID 28837642›Full record

ArticlePloS one2017

Hot-spot identification on a broad class of proteins and RNA suggest unifying principles of molecular recognition.

John L Kulp, Ian S Cloudsdale, John L Kulp, Frank Guarnieri

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Spectral analysis of molecular dynamics simulations on PDZ: MD sectors.Journal of biomolecular structure & dynamics · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

John L KulpConifer Point Pharmaceuticals, Doylestown, Pennsylvania, United States of America.
Ian S CloudsdaleConifer Point Pharmaceuticals, Doylestown, Pennsylvania, United States of America.
John L KulpConifer Point Pharmaceuticals, Doylestown, Pennsylvania, United States of America.
Frank GuarnieriPAKA Pulmonary Pharmaceuticals, Acton, Massachusetts, United States of America.ORCID http://orcid.org/0000-0003-0482-3509
Baruch S. Blumberg Institute · USPulmonary Associates · US

Funding

AN OPEN WEB SERVICE FOR FRAGMENT-BASED DESIGN OF SMALL MOLECULE INHIBITORSR43GM109549 · NIGMS · CONIFER POINT PHARMACEUTICALS, LLC · PI KULP, JOHN L · 2016 to 2016
$225k
NIGMS NIH HHS R43 GM109549
6 · The paper itself

Abstract

Chemically diverse fragments tend to collectively bind at localized sites on proteins, which is a cornerstone of fragment-based techniques. A central question is how general are these strategies for predicting a wide variety of molecular interactions such as small molecule-protein, protein-protein and protein-nucleic acid for both experimental and computational methods. To address this issue, we recently proposed three governing principles, (1) accurate prediction of fragment-macromolecule binding free energy, (2) accurate prediction of water-macromolecule binding free energy, and (3) locating sites on a macromolecule that have high affinity for a diversity of fragments and low affinity for water. To test the generality of these concepts we used the computational technique of Simulated Annealing of Chemical Potential to design one small fragment to break the RecA-RecA protein-protein interaction and three fragments that inhibit peptide-deformylase via water-mediated multi-body interactions. Experiments confirm the predictions that 6-hydroxydopamine potently inhibits RecA and that PDF inhibition quantitatively tracks the water-mediated binding predictions. Additionally, the principles correctly predict the essential bound waters in HIV Protease, the surprisingly extensive binding site of elastase, the pinpoint location of electron transfer in dihydrofolate reductase, the HIV TAT-TAR protein-RNA interactions, and the MDM2-MDM4 differential binding to p53. The experimental confirmations of highly non-obvious predictions combined with the precise characterization of a broad range of known phenomena lend strong support to the generality of fragment-based methods for characterizing molecular recognition.

Indexed as

Binding SitesOxidopamineProtein ConformationProteinsRNAOxidopamineProteinsRNA

Identifiers

PMID28837642
PMCPMC5570288
OpenAlexW2746371589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.